BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38683770)

  • 1. Factors associated with interobserver variation amongst pathologists in the diagnosis of endometrial hyperplasia: A systematic review.
    McCoy CA; Coleman HG; McShane CM; McCluggage WG; Wylie J; Quinn D; McMenamin ÚC
    PLoS One; 2024; 19(4):e0302252. PubMed ID: 38683770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
    Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
    Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
    Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
    Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.
    Kendall BS; Ronnett BM; Isacson C; Cho KR; Hedrick L; Diener-West M; Kurman RJ
    Am J Surg Pathol; 1998 Aug; 22(8):1012-9. PubMed ID: 9706982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.
    Usubutun A; Mutter GL; Saglam A; Dolgun A; Ozkan EA; Ince T; Akyol A; Bulbul HD; Calay Z; Eren F; Gumurdulu D; Haberal AN; Ilvan S; Karaveli S; Koyuncuoglu M; Muezzinoglu B; Muftuoglu KH; Ozdemir N; Ozen O; Baykara S; Pestereli E; Ulukus EC; Zekioglu O
    Mod Pathol; 2012 Jun; 25(6):877-84. PubMed ID: 22301705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
    Travaglino A; Raffone A; Saccone G; D'Alessandro P; Arduino B; de Placido G; Mascolo M; Insabato L; Zullo F
    Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification.
    Ordi J; Bergeron C; Hardisson D; McCluggage WG; Hollema H; Felix A; Soslow RA; Oliva E; Tavassoli FA; Alvarado-Cabrero I; Wells M; Nogales FF
    Histopathology; 2014 Jan; 64(2):284-92. PubMed ID: 24111732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
    Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
    Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia.
    Morrison ML; McCluggage WG; Price GJ; Diamond J; Sheeran MR; Mulholland KM; Walsh MY; Montironi R; Bartels PH; Thompson D; Hamilton PW
    J Pathol; 2002 Jul; 197(3):403-14. PubMed ID: 12115888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Endometrial Hyperplasia, Low-grade: "Much ADO About Nothing".
    D'Angelo E; Espinosa I; Cipriani V; Szafranska J; Barbareschi M; Prat J
    Am J Surg Pathol; 2021 Jul; 45(7):988-996. PubMed ID: 34105519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
    APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
    Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
    Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial intraepithelial neoplasia.
    Owings RA; Quick CM
    Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histological diagnosis of endometrial hyperplasia. Is there a need to simplify?
    Dietel M
    Virchows Arch; 2001 Nov; 439(5):604-8. PubMed ID: 11764378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.
    Raffone A; Travaglino A; Saccone G; Mascolo M; Insabato L; Mollo A; De Placido G; Zullo F
    Acta Obstet Gynecol Scand; 2019 Mar; 98(3):287-299. PubMed ID: 30511741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens.
    Bergeron C; Nogales FF; Masseroli M; Abeler V; Duvillard P; Müller-Holzner E; Pickartz H; Wells M
    Am J Surg Pathol; 1999 Sep; 23(9):1102-8. PubMed ID: 10478671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial hyperplasia as a risk factor of endometrial cancer.
    Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
    Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.